More than 12 billion rubles to be invested in the pharma industry of Irkutsk region

| By | Pharmasynthez, Preсlinical Studies
0
148

1.15 billion rubles from the federal and regional budgets will be allocated for establishing the center for preclinical tests. In addition, about 1 billion rubles of government investments are earmarked to establish a network of clinics in partnership with Korea.

“More than 12 billion rubles will be allocated, under the public-private partnership (PPP), to three projects aimed at developing the pharmaceutical industry in the Irkutsk region,” said Igor Bychkov, the Scientific Director at the Irkutsk Scientific Center of the Siberian Branch of the Russian Academy of Sciences.

“The plans provide for the establishment of the center for preclinical tests of substances in the Institute of Chemistry of the Siberian Branch of the Russian Academy of Sciences. Another project scheduled for implementation in the Institute of Chemistry together with the colleagues from South Korea provides for establishing a network of clinics specializing in traditional Eastern medicine. Its objective will be to develop not only natural active medicinal elements, but also to synthesize their chemical analogs,” said Mr. Bychkov.

He added that both projects “form a single scheme” with the plans of Pharmasyntez, the leader of pharmaceutical industry in Irkutsk region, that wants to build its new plant in Usolye-Sibirskoye, a priority development area. The phase one of the plant is estimated at 10 billion rubles.

Mr. Bychkov said that the construction of the plant in Usolye-Sibirskoye will be based on PPP arrangements providing that a part of investor’s funds will be compensated from the federal budget. He added that “the corresponding decree of the Russian government is currently being prepared.”

1.15 billion rubles from the federal and regional budgets will be allocated for establishing the center for preclinical tests. In addition, about 1 billion rubles of government investments are earmarked to establish a network of clinics in partnership with Korea.

“The implementation of both projects will begin in 2018,” said Mr. Bychkov.